Cas:132414-50-7 1-Benzyloctahydropyrrolo[3,4-b]pyrrole manufacturer & supplier

We serve Chemical Name:1-Benzyloctahydropyrrolo[3,4-b]pyrrole CAS:132414-50-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Benzyloctahydropyrrolo[3,4-b]pyrrole

Chemical Name:1-Benzyloctahydropyrrolo[3,4-b]pyrrole
CAS.NO:132414-50-7
Synonyms:1-benzyl-octahydro-pyrrolo[3,4-b]pyrrole;Pyrrolo[3,4-b]pyrrole, octahydro-1-(phenylmethyl)-;1-Benzyloctahydropyrrolo[3,4-b]pyrrole
Molecular Formula:C13H18N2
Molecular Weight:202.295
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:304.4±17.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.570
PSA:15.27000
Exact Mass:202.147003
LogP:1.42

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-benzyl-octahydro-pyrrolo[3,4-b]pyrrole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Benzyloctahydropyrrolo[3,4-b]pyrrole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyrrolo[3,4-b]pyrrole, octahydro-1-(phenylmethyl)- Use and application,Pyrrolo[3,4-b]pyrrole, octahydro-1-(phenylmethyl)- technical grade,usp/ep/jp grade.


Related News: To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early. 1-Benzyloctahydropyrrolo[3,4-b]pyrrole manufacturer Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings. 1-Benzyloctahydropyrrolo[3,4-b]pyrrole supplier One source familiar with the matter told Reuters that the J&J doses are expected to be exported to other countries. The doses are already in vials and ready for use, the other source said. 1-Benzyloctahydropyrrolo[3,4-b]pyrrole vendor To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early. 1-Benzyloctahydropyrrolo[3,4-b]pyrrole factory The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.